Lycopene, a natural pigment, was reported to have a modulatory effect on cytochrome P450, hence, metabolic clearance of some drugs. This research is concerned with studying the influence of lycopene on the pharmacokinetics of theophylline, a drug with a narrow therapeutic index. Lycopene (10 mg/kg) was intraperitoneally given to rats for eight consecutive days and on the eighth day of treatment, theophylline (5 mg/kg) was intravenously administered. Blood samples were withdrawn from rats at various time periods, treated and analyzed using HPLC. The HPLC method was based on isocratic elution of theophylline and caffeine as internal standard on ZORBAX Eclipse plus C8 column using a mobile phase consisting of water and methanol (80:20, v/v) at a flow rate of 1 mL min-1. Statistical analysis of the pharmacokinetic data using Paired t-test showed a significant decrease in AUC0–t and AUC0-∞ (about 22.140 and 23.824%, respectively,P < 0.05) and a significant increase in Vd and CL (1.28- and 1.40-fold, respectively, P < 0.05) of theophylline administered to rats pretreated with lycopene. Treatment with lycopene has a significant effect on the metabolic clearance and pharmacokinetics of theophylline in rats.
Similar content being viewed by others
References
J.Terao, Lipids, 24(7), 659 – 661 (1989).
A. V. Rao and S. Agarwal, Rev. Nutr. Res., 19, 305 – 323 (1999).
N. I. Krinsky, Proc. Soc. Exp. Biol. Med., 200, 248 – 254 (1992).
M. S. Ansari and N. P. Gupta, BJU Int., 92(4), 375 – 378 (2003).
L. Chen, M. S. Sapuntzakis, C. Duncan, et al., J. Natl. Cancer Inst., 93 (24), 1872–1879 (2001).
O. Kucuk, F. H. Sarkar, et al., Exp. Biol. Med. (Maywood), 227 (10), 881–885 (2002).
V. Bhuvaneswari and S. Nagini, Curr. Med. Chem. Anticancer Agents, 5 (6), 627–635 (2005).
E.Giovannucci, JNCI J. Natl. Cancer Inst., 91 (4), 317–331 (1999).
L. A. Cohen, Exp. Biol. Med., 227(10), 864 – 868 (2002).
E. S. MacKinnon, A. V. Rao, R. G. Josse, and L. G Rao, Osteoporos. Int., 22(4), 1091 – 1101 (2011).
A. C. Moffat, M. D. Osselton, and B.Widdop (Eds), Clarke’s Analysis of Drugs and Poisons, Pharmaceutical Press (2004).
G. Levy and R. Koysooko, J. Pediatr., 86(5), 789 – 793 (1975).
J.Kojima, H. Katoh, T.Taniguchi, et al., Meth. Find Exp. Clin. Pharmacol.,22(4), 247 – 252 (2000).
A. G.Muhammed Charehsaz, M. E. Karakilýç, and G. ªahin, J. Clin. Anal. Med., 2(3), 157 – 163 (2011).
P. A. Mitenko and R. I. Ogilvie, New Engl. J. Med., 289(12), 600 – 603 (1973).
T. J. Haley, Drug Metab. Rev., 14(2), 295 – 335 (1983).
H. Nosaka, M.Nadai, M.Kato, et al., Life Sci.,79(1), 50 – 56 (2006).
C. F. Chien, Y. T.Wu, W. C. Lee, et al., Chem. Biol. Interact., 184(3), 458 – 465 (2010)
N. Gao, Y. Fang, B, Qi, et al., J. Ethnopharmacol., 150 (2), 477–484 (2013).
T.Shimada, H. Yamazaki, M. Mimura, et al., J. Pharmacol. Exp. Ther., 270(1), 414 – 423 (1994).
K. S. Lee and S. K. Kim, J. Appl. Toxicol., 33(2), 100 – 108 (2013).
T. Antoniou, T. Gomes, M. M. Mamdani, and D. N. Juurlink, Eur. J. Clin. Pharmacol., 67(5), 521 – 526 (2011).
V. Breinholt, S. T. Lauridsen, B. Daneshvar, and J. Jakobsen, Cancer Lett.,154(2), 201 – 210 (2000).
N. I. Krinsky S. T. Mayne, and H. Sies (Eds.), Carotenoids in Health and Disease, CRC Press (2004).
EMA Guideline on Bioanalytical Method Validation, EMEA Comm. Med. Prod. Hum. Use., 44, 1 – 23 (2012).
Food and Drug Administration Guidance for Industry, Bioanalytical Method Development and Validation, US Department of Health and Human Services (2001).
C. Xu, C. Y.-T. Li., and A.-N. T. Kong, Arch. Pharm. Res., 28(3), 249 – 268 (2005).
A. Saxena, K. P. Tripathi, S. Roy, et al., Bioinformation, 3(5), 198 – 204 (2008).
R. S. Foti, L. C. Wienkers, and J. L. Wahlstrom. Comb. Chem. High Throughput Screen., 13(2), 145 – 158 (2010).
U. Fuhr, J.Doehmer, N. Battula, et al., Toxicology, 82(1 – 3), 169 – 189 (1993)
J. H. Lin and A. Y. Lu, Pharmacol. Rev., 49(4), 403 – 449 (1997).
Acknowledgements
The three authors contribute equally to this work.
Conflict Of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Author information
Authors and Affiliations
Corresponding author
Additional information
Russian Original Vol. 53, No. 11, November, 2019
Rights and permissions
About this article
Cite this article
Youssef, R.B., Fouad, M.A. & El-Zaher, A.A. Bioanalytical Study of the Effect of Lycopene on the Pharmacokinetics of Theophylline in Rats. Pharm Chem J 53, 1053–1058 (2020). https://doi.org/10.1007/s11094-020-02121-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-020-02121-1